Sub: Reconciliation of Share Capital Audit Report for the ... ... Sub: Reconciliation of Share Capital

  • View
    0

  • Download
    0

Embed Size (px)

Text of Sub: Reconciliation of Share Capital Audit Report for the ... ... Sub: Reconciliation of Share...

  • January 08, 2019

    The Corporate Relationship Department SSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

    GlaxoSmithKline Consumer Healthcare Ltd. 24-25 Floor, One Horizon Center Sector 43, DLF Phase 5, Golf Course Road Gurugram (Haryana), India - 122002

    T +91 124 4336500 F +91 124 4336600 E con tact. 4.gsk@gsk.com www.gsk.com

    The Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C - 1, Block - G Sandra Kurla Complex, Sandra Mumbai - 400 051

    Sub: Reconciliation of Share Capital Audit Report for the third quarter ended on December 31, 2018

    Dear Sir/ Madam,

    Pursuant to Regulation 55A of SEBI (Depositories & Participants) Regulations, 1996, we are enclosing herewith the Reconciliation of Share Capital Audit Report for the third quarter ended December 31, 2018.

    Please take the same on your record .

    Thanking You,

    For GlaxoSmithKline Consumer Healthcart' Limited

    ~ Shanu Saksena Company Secretary

    CIN: L24231PB1958PLC002257 Registered Office Patiala Road Nabha (Punjab}, India 14 7201

  • Page 1 of 6

    RECONCILIATION OF SHARE CAPITAL AUD IT

    Scrip code* 500676

    NSE Symbol GSKCONS

    MSE!Symbol NOTUSTED

    !SIN INE264A01014

    Name of the company* GLAXOSMITHKLINE CONSUMER HEAL TH CARE LIMITED

    Registered office address

    Registered office address* PATIALAROAD, NABHA-147201

    Registered office state* PUNJAB

    Registered office city* NABHA

    Registered office district* NABHA

    Registered office pin code* 147201

    Registered office contact ISO Code* STD Code* Number*

    number* +91 01765 306400

    Registered office fax 01765 220642

    Registered office country* INDIA

    Registered office website www.gsk.com

    Registered office email investor.2.co@gsk.com

    Correspondence address

    Same as above No

    Correspondence address 24th FLOOR, ONE HORJZON CENTER, SECTOR 43, DLF PHASE 5, GOLF COURSE ROAD, GURUGRAM

    Correspondence state HARYANA

    Correspondence city GURUGRAM

    Correspondence district GURUGRAM

    Correspondence pin code 122002

    ISO Code STD Code Number Correspondence contact number

    +91 124 4336500

    Correspondence fax 124 4336500

    Correspondence country INDIA

    Correspondence email investor.2.co@gsk.com

    Reporting quarter* 31-12-2018

    Face value* 10

    Stock Exchange Details : Name of stock Exchange Listed % Of total issued

    Capital capital

    BSE Ltd 42055538 100 Name of other stock exchanges where the company's

    National Stock Exchange of India securities are listed 42055538 100 Ltd(NSE)

    Remarks

    file:///Z:/Personal%20Folders/Rishubh/20 l 8-19/Stock%20exchange%20S ubmissions/... 08-01-2019

  • Page 2 of 6

    Capital Details :

    Number of shares % Of total issued capital

    Issued capital* 42055538

    Listed capital (BSE) (As per company records)* 42055538 100

    Held in dematerial ised fonn in CDSL * 83893 I 1.99

    Held in demalerialised fonn in NSDL * 40583685 96.5

    Physical* 632922 1.5

    Total no.of shares* 42055538 100

    Reasons for difference if any, Between issued capital and !isled capital* 0

    Reasons for difference if any, Between issued capital and total number of shares* 0

    Reasons for difference if any, Between !isled capital and total number of shares* 0

    file:///Z:/Personal%20Folders/Rishubh/2018-l 9/Stock%20exchange%20Submissions/... 08-01-2019

  • Page 3 of 6

    Certifying the details of changes in share capital during the quarter under consideration as per Table below :

    Whether changes during the quarter*

    Register of members is updated* Yes

    If not, Updated upto which date

    Reference of previous quarter with regards to excess dematerialised shares,lf any. NIL

    Has the company resolved the matter (excess dematerialised shares mentioned above) in the current quarter?* NA

    If not, Reason why?

    file:///Z:/Personal%20Folders/Rishubh/20 l 8- l 9/Stock%20exchange%20Submissions/... 08-01-2019

  • Page 4 of 6

    Mentioned the total no.of requests, If any, confirmed after 21 days and the total no.of requests pending beyond 21 days with the reasons for delay

    Total no.of demat requests No.of requests* No.of shares* Reasons for delay

    Confirmed after 2 1 days* 0 0

    Pending for more than 2 1 days* 0 0

    Remarks

    Compliance Officer Details

    Whether Qualified Company Secretary is Compliance Officer • Yes

    Name of the compliance officer* Shanu Saksena

    Date of Appointment • 05-08-2016

    Designation* Company Secretary

    Membership Nos F9733

    Telephone no.* 0 I 24-4336500

    Fax no. 0124-4336500

    E-mail id* sl1anu.s.saksena@gsk.co1n

    Whether any change in Compliance Officer during the quarter • No

    Whether the previous Compliance Officer was Qualified Company Secretary• Yes

    file :///Z:/Personal%20Folders/Rishubh/2018- l 9/Stock%20exchange%20Submissions/. .. 08-01-2019

  • Page 5 of 6

    Details of Previous Compliance Officer

    Previous Compliance Officer Name

    Membership Nos

    Date of Appointment

    Date of Cessation

    file :///Z:/Personal%20Folders/Rishubh/2018-19/Stock%20exchange%20Submissions/... 08-01-2019

  • Page 6 of 6

    Certifying Auditor Details

    CNCS* Company secretary

    Name of certifying auditor* S. ANAND S.S.RAO

    Date of issue of report* 07-01-2019

    Address* 511, KANCHANJUNGA BLOCK, ADITYA ECLA VE, AMEERPET, HYDERABAD - 500038

    City* HYDERABAD

    Pincode* 500038

    Contact no.* 040-23738398

    Fax no. 040-23738398

    Email

    Membership no.* 5716

    Finns registration number of audit finn

    Name of the finn* S. ANAND S.S.RAO

    COP number* 5687

    Registrar and Share Transfer Agent Details

    Appointment of common agency for share registry work* Yes

    Name ofRTA Karvy Fintech Private Limited (KARVY COMPUTERSHARE PRIVATE LIMITED )

    SEBI registration no. INR00000022 I

    Address KAR VY SELENIUM TOWER B, PLOT 31-32, GACHIBOWLI, FINANCIAL DISTRICT

    State HYDERABAD

    City NANAKRAMGUDA

    Pincode 500032

    Contact no. 9140-67161500

    Fax number of RTA 9140-67161500

    E-mail id einward.ris@karvy.com

    Website Address https:/ /www.karvy.com

    Whether any change in Registrar and Share Transfer Agents*· No

    Previous Registrar and Share Transfer Agents Name

    Date of Cessation

    Any other detail that the auditor may like to provide. (e.g. BIFR company, delisting from SE)

    file:///Z:/Personal%20Folders/Rishubh/20 l 8-l 9/Stock%20exchange%20S ubmissions/... 08-01-2019

  • Os S ANAND SS RAO M.Com., LLB., F.C.S COMPANY SECRETARY IN PRACTICE Flat No.511, Kanchanjunga Aditya Enclave, Ameerpet, Hyderabad - 500038. Mobile 092461 53677 Tele 040 23738398 Fax 040 23738398 E-mail .. anandssrao@gmail.com Website www.anandssrao .com

    RECONCILIATION OF SHARE CAPITAL AUDIT REPORT FOR THE QUARTER ENDED 3112 2018.

    I. Report for quarter ended 3112 2018 2. ISIN INE264AO IO 14 3. Face Value Rs. I 0/- each 4. Name of the Comp:lllY GlaxoSmithKJine Consumer

    Healthcare Limited 5. Registered Office Address Patiala Road, Nabha - 147 201 6. Correspondence Address 24th Floor, One Horizon Center, DLF

    Phase 5, Golf Course Road, Gurgaon 122002, Jndia

    7. Telephone and Fax Nos. Tel +0124 - 4336266 Fax+ 0124 - 4336600

    8 Email Address shanu.s.saksena@!lsk.com 9. Name of the Stock Exchange where the company's

    Securities are listed : Bombay Stock Exchange Limited National Stock Exchange of India Limited

    10. Issued Capital

    11. Listed Capita l (Exchange Wise) All (as per company records)

    12. Held in dematerial ised form in CDSL

    13. Held in dcmaterialiscd form in NSDL

    14, Physical

    15. Total No. of S hares (12+13+14)

    16. Reasons for differences if any, between (IO& 11), (IO&JS), (11& 15)

    Number of Shares · % of Total Issued Capital

    42055538 100 42055538 100

    838931 1.99 40583685 96.50

    632922 1.51 42055538 100.00

    NA

    17. Certifying the details of changes in share capital during the quarter under consideration as per Table below· NIL Particulars No. of Appl ied / Listed on Stock Whether Whether In-principle

    Shares Not Exchange intimated intimated ·approva l Pending Appli ed for (Specify name) to CDSL to NSDL from ·Stock • listing Exchange(s)

    (Specify Names) NIL

    18, Register of Members is updated (Yes /No) -YES- If not, updated upto which date -N.A-

  • 19. Refe rence of previous quarter with regard to excess dematerialized shares, if any: -NJL-

    20. Has the Company resolved the matter mentioned in Point No .1 9 above, in the current quarter? If not reason why? -NA- 21. Met1tion the total no. of requests, if any, confirmed after 21 days and the total no. of requests pending b d 2 1 d . h I fi d I NIL evon avs wit t 1e reasons or e av. - -

    No. ofreauests . Confirmed after 21 days -NIL- Pending for more than 21 davs -NIL-

    22. Name, Telephone & Fax No . of Compliance Officer of the company

    23 . N